Escalon Medical Gross Profit

As of the most recent data (March 2026), ESMC shows a gross profit of $3.6B. That compares with $5.9M in the prior-year period — up 61764.5% year over year. That is above the sector sector average of $760M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ESMC's gross profit is now $3.6B (was $5.9M) — a 61764.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Escalon Medical is outperforming or lagging.

The its sector sector average gross profit is about $760M. Escalon Medical is at $3.6B, which is higher that average. That is roughly 376.2% above the sector mean. Use the comparison chart on this page to see how ESMC stacks up against individual peers as well.

Tracking ESMC's gross profit over time shows whether Escalon Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $3.6B That compares with $5.9M in the prior-year period — up 61764.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this gross profit page, Stockcircle has Escalon Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect gross profit (currently $3.6B) with ownership activity and broader fundamentals.